SPE product for urine drug testing
June 2018—Phenomenex introduced Strata-X-Drug B Plus, a solid-phase extraction sample preparation product for urine drug testing in clinical and forensic toxicology laboratories.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2018—Phenomenex introduced Strata-X-Drug B Plus, a solid-phase extraction sample preparation product for urine drug testing in clinical and forensic toxicology laboratories.
June 2018—DiaSorin received clearance from the FDA to market the Liaison Brahms PCT II Gen assay for the quantitative determination of procalcitonin.
June 2018—Aurora Diagnostics announced that Cascade Pathology Services, a physician-owned multispecialty pathology practice providing surgical pathology services to hospitals and physician groups in the Portland area, has joined Aurora Diagnostics.
June 2018—Beckman Coulter Diagnostics launched its Access Sensitive Estradiol in the U.S. and in the majority of worldwide markets. The assay aims to help laboratories deliver more accurate results for patients seeking answers to reproductive health questions.
June 2018—SciGene introduced the CytoBrite Plus Slide Incubation System, a programmable FISH hybridizer with onboard temperature verification of each slide position, as required by CAP cytogenetics checklist item CYG.33950.
June 2018—Medtronic received FDA approval for its Guardian Connect continuous glucose monitoring system for people with diabetes ages 14 to 75 years.
June 2018—Becton Dickinson announced the commercial availability of the CE-IVD-marked PAXgene Blood ccfDNA tube within the European Economic Area and Switzerland.
June 2018—Binding Site’s Immunologicals Group announced the availability of affinity-purified, unconjugated, anti-human antibodies to the IgG subclasses, including IgG1, IgG2, IgG3, and IgG4, for IVD research use in solid phase enzyme immunoassay based test methods, especially ELISAs, and other potential testing applications.
June 2018—Rosetta Genomics’ stockholders have approved the acquisition of the company by Genoptix, which will immediately begin marketing, selling, and distributing Rosetta Genomics’ products.
June 2018—Sekisui Diagnostics has partnered with Qualigen to distribute the FastPack IP System, Qualigen’s POC immunoassay testing system.